C21H22Cl2FN5O
Neat
450.34
-20°C
Room Temperature
(S)-crizotinib; ent-crizotinib; 3-[(1s)-1-(2, 6-Dichloro-3-Fluorophenyl)ethoxy]-5-(1-Piperidin-4-Ylpyrazol-4-Yl)pyridin-2-Amine; CHEBI:77555; 3-((1S)-1-(2, 6-dichloro-3-fluorophenyl)ethoxy)-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine; RefChem:70478; 1374356-45-2; 2-Pyridinamine, 3-[(1S)-1-(2, 6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-; (S)-3-(1-(2, 6-DICHLORO-3-FLUOROPHENYL)ETHOXY)-5-(1-(PIPERIDIN-4-YL)-1H-PYRAZOL-4-YL)PYRIDIN-2-AMINE; CHEMBL1825141; 3-[(1S)-1-(2, 6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-pyridinamine; C21H22Cl2FN5O; 3-[(1S)-1-(2, 6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-amine; Crizotinib S-Isomer; S-CRIZOTINIB; crizotinib-(S); MFCD22126092; Crizotinib and (S)-; 4SF5Q86VXC; (S)-crizotinibent-crizotinib
3-[(1S)-1-(2 and 6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine
InChI=1S/C21H22Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27)/t12-/m0/s1